Ledger.Open graph →
SEC Form D · filed June 2, 2021

Xalud Therapeutics, Inc

Offering
$30.0M
Sold
$18.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jayson Rieger · San Carlos, CADirectorSean Stalfort · San Carlos, CADirectorStephen Collins · Nashville, TNExec · DirectorPaul B. Manning · Berkeley, CADirectorDiem B. Nguyen · CHARLOTTESVILLE, VAExec · DirectorJayson Rieger · San Carlos, CADirectorSean Stalfort · San Carlos, CADirectorStephen Collins · St. Petersburg, FLExec · DirectorPaul B. Manning · Berkeley, CADirectorDiem B. Nguyen · CHARLOTTESVILLE, VAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗